Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02723305 · ClinicalTrials.gov registry record

Cardiometabolic Profiles of Boys With Klinefelter Syndrome

A clinical trial of Klinefelter Syndrome and Sex Chromosome Aneuploidy, sponsored by University of Colorado, Denver.

Completed
Registry status
31
Enrollment target
1
Study location

NCT02723305: Completed study of Klinefelter Syndrome and Sex Chromosome Aneuploidy, sponsored by University of Colorado, Denver.

NCT02723305 is a study of Klinefelter Syndrome and Sex Chromosome Aneuploidy that has completed, run by University of Colorado, Denver. The registered enrollment target is 31 participants, below the 281-participant average among 4 other Klinefelter Syndrome trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02723305, a study of Klinefelter Syndrome and Sex Chromosome Aneuploidy, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
31 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such as diabetes, extra weight gain, heart disease and liver diseases.

Primary Outcome

The primary outcome will be peak oxygen consumption (VO2 peak) during exercise on a bicycle ergometer

Interventions

  • OTHER No intervention

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2016-05
Est. Completion 2017-12
University of Colorado, Denver

1,283 total trials

What the finished NCT02723305 record still lists

NCT02723305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 281-participant average among 4 other Klinefelter Syndrome trials with a reported enrollment target (89% lower).

The record links to 4 conditions, with Klinefelter Syndrome appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT02723305 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT02723305 about?

NCT02723305 is a clinical study titled "Cardiometabolic Profiles of Boys With Klinefelter Syndrome". This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such ...

What is the current status of trial NCT02723305?

This trial is currently completed. The enrollment target is 31 participants. The study started on 2016-05. Estimated completion is 2017-12.

What conditions does trial NCT02723305 study?

This clinical trial studies the following conditions: Klinefelter Syndrome, Sex Chromosome Aneuploidy, 47,XXY, XXY Syndrome.

What interventions are being tested in trial NCT02723305?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT02723305?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02723305 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Klinefelter Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02723305, the US trial registry maintained by the National Library of Medicine. NCT02723305 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.